In a 15-year-old female with fatigue, orthostatic dizziness, heavy menstrual bleeding lasting 7–8 days, pale conjunctiva, and microcytic anemia (hemoglobin 10.2 g/dL, MCV 74 fL), what are the most likely differential diagnoses according to current ACOG and pediatric guidelines?

Most Likely Differential Diagnosis: Iron Deficiency Anemia Secondary to Heavy Menstrual Bleeding

The most likely diagnosis in this 15-year-old female is iron deficiency anemia (IDA) caused by heavy menstrual bleeding (HMB), with an underlying bleeding disorder—particularly von Willebrand disease (VWD)—as a critical secondary consideration that must be actively evaluated.

Primary Diagnosis: Iron Deficiency Anemia from Heavy Menstrual Bleeding

The clinical presentation is classic for IDA:

• Microcytic anemia (MCV 74 fL, normal 80-100 fL) with hemoglobin 10.2 g/dL (below WHO threshold of 12 g/dL for non-pregnant females >15 years) 1
• Heavy menstrual bleeding lasting 7-8 days (normal is ≤7 days)
• Symptoms of anemia: fatigue, orthostatic dizziness, pale conjunctiva
• Adolescent female: This demographic has the highest prevalence of microcytic anemia, with rates increasing from 7.8% at ages 12-13 to 12.5% at ages 17-18 2

Critical Diagnostic Steps

Confirm iron deficiency immediately with:

• Serum ferritin (most specific test): <15 μg/L confirms absent iron stores; <30 μg/L indicates low stores; <45 μg/L warrants investigation in context of HMB 1
• Ferritin is essential because 50.9% of adolescents with HMB have iron deficiency, but only 41.4% are anemic and 46.3% are microcytic 3—meaning hemoglobin and MCV alone miss over half of iron deficiency cases

Critical Secondary Diagnosis: Underlying Bleeding Disorder

You must actively screen for bleeding disorders, particularly von Willebrand disease, as 13.7% of adolescents with HMB have an underlying bleeding disorder 4, 5.

When to Suspect a Bleeding Disorder (per ACOG guidelines) 6:

• Menses >7 days (✓ present in this patient)
• Soaking >5 sanitary products per day or requiring nighttime changes
• Passage of large blood clots
• Failure to respond to conventional hormonal therapy
• Personal or family history of other bleeding symptoms (easy bruising, epistaxis, gingival bleeding, prolonged bleeding from minor cuts)

Specific Testing for von Willebrand Disease 7:

Initial screening:

• VWF antigen (VWF:Ag) and VWF activity
• Factor VIII coagulant activity (FVIII:C)
• Complete blood count (already done)

Diagnostic thresholds (2025 guidelines):

• Type 1 VWD: VWF:Ag and/or VWF activity <0.30 IU/mL
• For patients with abnormal bleeding: VWF:Ag and/or VWF activity <0.50 IU/mL confirms diagnosis
• Type 3 VWD: VWF:Ag and activity <0.05 IU/mL, FVIII:C <0.10 IU/mL

Critical timing consideration: Testing should ideally be delayed until resolution of active bleeding and anemia correction, as acute bleeding and stress can falsely elevate VWF levels 7. However, given the severity of symptoms, initial screening can proceed with the understanding that repeat testing may be necessary.

Additional Differential Considerations

Thalassemia Trait

• Key distinguishing feature: MCV typically reduced out of proportion to the degree of anemia 1
• In this patient, MCV 74 fL with Hb 10.2 g/dL is proportionate to iron deficiency
• Hemoglobin electrophoresis is recommended if iron studies are normal, particularly in patients of Mediterranean, African, Middle Eastern, or Southeast Asian descent 1

Anemia of Chronic Disease

• Less likely in an otherwise healthy adolescent
• Would typically show normal or elevated ferritin (as an acute phase reactant) 1

Hypothalamic-Pituitary-Ovarian (HPO) Axis Immaturity

• Most common cause of HMB in adolescents (63.9% of cases) 4
• Causes anovulatory bleeding leading to prolonged, irregular menses
• This is likely the mechanism of HMB in this patient, but the consequence is still IDA

Diagnostic Algorithm

Step 1: Confirm iron deficiency

• Serum ferritin (target <15-30 μg/L confirms IDA)
• If ferritin 15-45 μg/L with microcytic anemia and HMB, treat as IDA

Step 2: Assess bleeding disorder risk

• Detailed bleeding history (personal and family)
• If ANY red flags present: VWF:Ag, VWF activity, FVIII:C, PT/PTT

Step 3: Rule out hemoglobinopathy if indicated

• Hemoglobin electrophoresis if: iron studies normal OR appropriate ethnic background OR MCV disproportionately low

Step 4: Assess severity

• Orthostatic vital signs (already showing dizziness on standing)
• Hemoglobin <10 g/dL warrants more aggressive management 6

Common Pitfalls to Avoid

1. Relying on hemoglobin/MCV alone: This misses >50% of iron deficiency in adolescents with HMB 3
2. Missing bleeding disorders: VWD prevalence is significantly elevated in adolescents with HMB 5, 8
3. Delaying ferritin measurement: This is the single most useful marker and should be obtained immediately 1
4. Assuming HPO immaturity excludes other diagnoses: While common, it doesn't explain the microcytic anemia—iron deficiency does
5. Testing VWF during active bleeding: May yield false-normal results; consider timing but don't delay if clinical suspicion is high 7

Impact on Morbidity and Quality of Life

• Untreated IDA causes persistent fatigue, impaired cognitive function, and reduced quality of life 5
• Undiagnosed bleeding disorders lead to recurrent anemia, potential need for transfusion, and surgical complications if not recognized before procedures 6
• Early diagnosis and treatment of both IDA and underlying bleeding disorders significantly improves quality of life and prevents hospitalization 5, 6